| Schedule of Impacts to Consolidated Financial Statements |
Schedule
of Impacts to Consolidated Financial Statements
| | |
As Previously
Reported | | |
Adjustments | | |
As Restated | |
| | |
As Previously
Reported | | |
Adjustments | | |
As Restated | |
| Condensed Consolidated Balance Sheet as of March 31, 2025 | |
| | | |
| | | |
| | |
| Common stock subject to possible redemption | |
$ | 2,822,505 | | |
$ | 563,108 | | |
$ | 3,385,613 | |
| Accumulated deficit | |
| (11,021,551 | ) | |
| (406,723 | ) | |
| (11,428,274 | ) |
| Additional paid in capital | |
| 935,133 | | |
| (156,385 | ) | |
| 778,748 | |
| Total Stockholders’ Deficit | |
| (10,082,973 | ) | |
| (563,108 | ) | |
| (10,646,081 | ) |
| Redemption value per redeemable common stock | |
| 10.17 | | |
| 2.03 | | |
| 12.20 | |
| | |
| | | |
| | | |
| | |
| Condensed Consolidated Statement of Operations (unaudited) for the Three Months ended March 31, 2025 | |
| | | |
| | | |
| | |
| Basic and diluted net income per share, Common stock – redeemable | |
$ | (0.18 | ) | |
$ | 0.52 | | |
$ | 0.34 | |
| Basic and diluted net loss per share, Common stock – non-redeemable | |
| (0.20 | ) | |
| (0.04 | ) | |
| (0.24 | ) |
| | |
| | | |
| | | |
| | |
| Condensed Consolidated Statement of Changes in Stockholders’ Deficit (unaudited) for the Three Months Ended March 31, 2025 | |
| | | |
| | | |
| | |
| Remeasurement of common stock subject to redemption | |
$ | (5,714 | ) | |
$ | (156,385 | ) | |
$ | (162,099 | ) |
| | |
| | | |
| | | |
| | |
| Condensed Consolidated Statement of Cash Flows (unaudited) for the Three Months Ended March 31, 2025 | |
| | | |
| | | |
| | |
| Remeasurement of Common stock subject to redemption | |
$ | 5,714 | | |
$ | 156,385 | | |
$ | 162,099 | |
|
Schedule
of Impacts to Consolidated Financial Statements
| | |
| | | |
| | | |
| | |
| | |
As Previously Reported | | |
Adjustments | | |
As Restated | |
| Consolidated Balance Sheet as of December 31, 2024 (audited) | |
| | | |
| | | |
| | |
| Common stock subject to possible redemption | |
$ | 2,816,791 | | |
$ | 406,723 | | |
$ | 3,223,514 | |
| Accumulated deficit | |
| (10,282,996 | ) | |
| (406,723 | ) | |
| (10,689,719 | ) |
| Total Stockholders’ Deficit | |
| (10,279,551 | ) | |
| (406,723 | ) | |
| (10,686,274 | ) |
| Redemption value per redeemable common stock | |
| 10.15 | | |
| 1.47 | | |
| 11.62 | |
| | |
| | | |
| | | |
| | |
| Consolidated Statement of Operations (audited) for the year ended December 31, 2024 | |
| | | |
| | | |
| | |
| Basic and diluted net income per share, Common stock – redeemable | |
$ | 0.26 | | |
$ | 0.10 | | |
$ | 0.36 | |
| Basic and diluted net loss per share, Common stock – non-redeemable | |
| (0.47 | ) | |
| (0.07 | ) | |
| (0.54 | ) |
| | |
| | | |
| | | |
| | |
| Consolidated Statement of Changes in Stockholders’ Deficit (audited) for the year ended December 31, 2024 | |
| | | |
| | | |
| | |
| Remeasurement of common stock subject to redemption | |
$ | (1,768,457 | ) | |
$ | (406,723 | ) | |
$ | (2,175,180 | ) |
| | |
| | | |
| | | |
| | |
| Consolidated Statement of Cash Flows (audited) for the year ended December 31, 2024 | |
| | | |
| | | |
| | |
| Remeasurement of Common stock subject to redemption | |
$ | 1,768,457 | | |
$ | 406,723 | | |
$ | 2,175,180 | |
|